-Kafila.org The lawyers collective condemns the blatant attempt of the government of India to victimize the organization and its office bearers India Jaisng and Anand Grover .This is noting but a gross misuse of the FCRA Act which is being used to suppress any form of dissent . it is far too well know that both Anand Grover and Indira Jaising have represented several persons in their professional capacity as lawyers...
More »SEARCH RESULT
Total Matching Records found : 943
With small team, India struggles to set the agenda at WHO meet -D Ravi Kanth
-Livemint.com The 69th meet of the World Health Assembly began with a call to address unprecedented challenges facing the global health sector Geneva: Despite carrying the highest disease burden in the world, the Narendra Modi government chose to send a small delegation to the World Health Assembly (WHA) that began on Monday, giving the country little say in the way the global health agenda is being set and inadequately reflecting its priorities,...
More »Patently a missed opportunity -Achal Prabhala and Sudhir Krishnaswamy
-The Hindu India’s first IPR policy trots out the worn western fairy tale that more IP means innovation, and encourages the pointless privatisation of indigenous knowledge India’s National Intellectual Property Rights (IPR) Policy, released in mid-May, is a bewildering document. There are two ways to read this policy. The first is as a gigantic exercise in dissimulation, with a terse declaration — India is not changing its IPR laws — tucked inside...
More »State to provide cheaper generic drugs -Sharad Vyas
-The Hindu Medicines will be available at 100 subsidised stores across Maharashtra Mumbai: Generic Medicines may now be available at one-fourth the price of branded Medicines at more than 100 subsidised stores that the Centre plans to open in Maharashtra over the next six months. Union minister for pharmaceuticals Ananth Kumar, and Minister of State for chemicals and fertiliser Hansraj Gangaram Ahir on Monday signed a Memorandum of Understanding (MoU) with the State...
More »Intellectual Property Rights policy may hinder drug access -Vidya Krishnan and Puja Mehra
-The Hindu The policy fails to acknowledge that IP is a market-driven model’ India’s National Intellectual Property Rights (IPR) policy, unveiled on Friday, could pose a “serious” hurdle to allowing access to affordable drugs and the South Asian nation missed a chance to put in place a progressive policy, according to experts. The policy left the country’s patent laws intact and specifically did not open up Section 3(d) of the Patents Act, which...
More »
